...Push Gardasil to achieve greater vaccination rates Less then a month after a JAMA article critized Merck for aggressively marking Gardasil, Merck is planning a big-time advertising push on Gardasil, hoping to revive flagging sales of the human papillomavirus vaccine. As … [Read more...] about Merck’s Back-to-School Special…
Merck & Co.
I received an email from my ICAP associate, Christina England today. Her message explained a mystery I have been trying to solve for the past week. My site stats have indicated a large number of hits from Russian ISPs and those visitors spending time investigating my article … [Read more...] about ICAP HPV Vaccine Papers Noted in Russian Media
Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a … [Read more...] about Merck Puts Some of Their Gardasil Cash To Work
Will Open Source "SAGE" platform lead to more transperency to MERCK's research and clinical trials process?Consumers can only hope. Of course if MERCK corporate lawyers figure out that such an open source platform may lead to a clear chain of custody of the type of … [Read more...] about Merck Execs See ‘Sage’ as Key Ingredient for Disease Biology
Vaccine Watchdog Group Calls for Transparency WASHINGTON--(BUSINESS WIRE)--The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal … [Read more...] about NVIC Says Government Denies Gardasil Risks